EP3494966
IMMUNE-MODIFYING PARTICLES FOR THE TREATMENT OF INFLAMMATION
:
EP einkaleyfi: Þýðing ekki lögð inn:
13.3.2014:
3.4.2024:
18192279.0
:
12.3.2034
:
IMMUNE-MODIFYING PARTICLES FOR THE TREATMENT OF INFLAMMATION
13.3.2014
3.4.2024
:
onCOUR Pharma, Inc.:
2215 Sanders Road Suite 428, Northbrook, IL 60062, US
:
KING, Nicholas:
Petersham, New South Wales 2049, AU
:
GETTS, Daniel:
Washington, District of Columbia 20018, US
:
201361779182 P:
13.3.2013:
US
:
201361844961 P:
11.7.2013:
US
:
201361865392 P:
13.8.2013:
US
:
201361887212 P:
4.10.2013:
US
:
A61K 9/00, A61K 39/39, A61K 39/00, A61K 31/01, A61K 31/74, A61K 31/765, A61K 31/78, G01N 33/68, A61P 1/04, A61P 3/10, A61P 5/50, A61P 7/02, A61P 9/00, A61P 9/08, A61P 11/02, A61P 11/06, A61P 17/00, A61P 17/04, A61P 17/06